BRTX 8-K 2026-09-02

BioRestorative Therapies, Inc. (BRTX) 8-K dated 2026-09-02 — accession 0001213900-26-096810. This URL is the filing, not the BRTX hub.

BioRestorative Therapies, Inc. (BRTX) is a biotechnology company listed on NASDAQ.

BioRestorative Therapies, Inc. filed a 8-K on 2026-09-02. Accession 0001213900-26-096810.

Cached items: 3.03, 5.03, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.

Not investment advice. The BRTX SEC hub lists recent forms. The stock page is the research view.